Precision medicine for pediatric cancers: New hope for children and adolescents

In 87% of patients, the study identified genomic anomalies that allowed for better patient management, either through better follow-up of residual disease, reclassification of the disease, or through the application of targeted therapy or to guide treatment and identify options for future personalized targeted therapy.

Leave a Reply

Your email address will not be published.